SCHEMBL31140656

SCHEMBL31140656

COc1ncccc1C(O)c1cc(F)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 1/20 0.41
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 3/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
ALK Q9UM73 3/20 0.38
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
CARM1 Q86X55 2/20 0.36
PRMT6 Q96LA8 1/20 0.36
ACHE P22303 1/20 0.36
TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25283525 1.00 P2RY1 (0.41) P2RY1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL21831822 0.81 SLC6A2 (0.44) P2RY1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL1631148 0.81 ACHE (0.47) P2RY1MAPTCES2CES1ACHE
SCHEMBL25241561 0.77 PSEN1 (0.36) CES2CES1
SCHEMBL4117333 0.73 CYP3A4 (0.43) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL25227231 0.72 CYP2D6 (0.45) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL23363180 0.72 CYP2D6 (0.45) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL29757465 0.72 CYP2D6 (0.45) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL23363181 0.72 CYP2D6 (0.45) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL1632053 0.72 MAPT (0.47) SLC6A2SLC6A4SLC6A3MAPTCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118525018-A Bialkyne compound and application thereof 上海艾力斯医药科技股份有限公司 2024-08-20 CN disclosed